ReleaseWire

PharmaPoint: Major Depressive Disorder - US Drug Forecast and Market Analysis to 2023

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Relmada Therapeutics, which currently conducts its operations through Camp Nine, Inc. (the "Company"), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that Sergio Traversa, Chief Executive Officer, will be presenting at the 2014 BIO International Convention on Thursday, June 26, at 9:30 AM. PDT. The presentation will take place in the Solana Beach room. Hosted by the Biotechnology Industry Organization (BIO), this year's global event for biotechnology will take place June 23-26 at the San Diego Convention Center in San Diego, California.

Global Markets Direct's, 'Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2014', provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer)'s therapeutic pipeline.

Global Markets Direct's, 'ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2014', provides an overview of the ImmunoCellular Therapeutics, Ltd.'s pharmaceutical research and development focus.

Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Spain pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

The present report on "North America Nutraceuticals Industry Outlook to 2017 - Increasing Demand from Ageing Population to Drive Growth" gives a comprehensive analysis of the industry past, present and future outlook. The report discusses The US and Canada market with outlook to 2017. Statistics include functional food, functional beverages and dietary supplements. Additionally the sub-segments of the industry, ongoing trends and developments, import and export scenario, government regulations and impact and highlight major players operating in the industry.

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Canada pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

GlobalData's clinical trial report, "Pituitary ACTH Hypersecretion (Cushing's Disease) Global Clinical Trials Review, H1, 2014" provides data on the Pituitary ACTH Hypersecretion (Cushing's Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pituitary ACTH Hypersecretion (Cushing's Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pituitary ACTH Hypersecretion (Cushing's Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Active Biotech AB - Product Pipeline Review - 2014', provides an overview of the Active Biotech AB's pharmaceutical research and development focus.

Global Markets Direct's, 'Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2014', provides an overview of the Relapsed Acute Myeloid Leukemia's therapeutic pipeline.

Global Markets Direct's, 'Dynavax Technologies Corporation - Product Pipeline Review - 2014', provides an overview of the Dynavax Technologies Corporation's pharmaceutical research and development focus.

Toxoplasmosis - Pipeline Review, H1 2014

The report titled "Germany Nutraceuticals Industry Outlook to 2017 - Growing Popularity of Functional Food and Beverages to Sustain Growth" provides a detailed analysis of the nutraceutical industry covering various aspects including market size in terms of revenues and market segmentation on the basis of major categories such as dietary supplements and functional food & beverages. The report also includes competitive landscape and profiles of the major players operating in the industry. The future projections are included to provide an insight on the prospects in the Germany nutraceuticals industry.

Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Norway pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Global Markets Direct's, 'NPS Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the NPS Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Hepatitis A - Pipeline Review, H1 2014

EY has announced that Roy Hirshland, President and CEO of T3 Advisors, a global real estate consulting firm, received the EY Entrepreneur Of The Year™ 2014 Award for New England. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Hirshland was selected by an independent panel of judges, and the award was presented at a special gala event at the Sheraton Boston on June 10.

Bacillus Anthracis Infections - Pipeline Review, H1 2014

Male Infertility - Pipeline Review, H1 2014

Global Markets Direct's, 'Hypoglycemia - Pipeline Review, H1 2014', provides an overview of the Hypoglycemia's therapeutic pipeline.

The present report on "France Nutraceuticals Industry Outlook to 2017 - Shift from Curative to Preventive Measures to Impel Growth" gives a comprehensive analysis of the industry past, present and future outlook. It provides a detailed analysis of the industry covering various aspects including market size in terms of revenues and market segmentation on the basis of major types such as dietary supplements and functional food and beverages. Additionally the sub-segments of the industry, ongoing trends and developments, government regulations and impact and highlight major players operating in the industry The future projections are included to provide an insight on the prospects in France nutraceuticals industry.

Global Markets Direct's, 'Jazz Pharmaceuticals plc - Product Pipeline Review - 2014', provides an overview of the Jazz Pharmaceuticals plc's pharmaceutical research and development focus.